TrademarkDashboard — A $1.2M Shopify exit, undone in 3 months.
Healthtech · Care · Regulated AI
Clinical-meets-commercial reporting on healthtech and care AI — careful on regulation, rigorous on claims.
Lead · Dr Priya Anand
New Birdie research lays bare a governance vacuum at the heart of UK homecare: adoption is racing ahead of rules, and regulators are only beginning to catch up.
5 August 2026 · 3 min read
Dr Priya Anand · 4 min read
Two days after the King's Fund called for a national strategy on ambient voice technology, the MHRA has drawn the regulatory line between a productivity tool and a medical device. The distinction will reshape procurement, IP strategy, and liability for every supplier in this fast-growing market.
Dr Priya Anand · 3 min read
Published yesterday, the MHRA's long-awaited ambient voice technology guidance finally tells developers which AI scribe functions need medical device approval and which don't. For a market that has been operating in deliberate ambiguity for over a year, the stakes couldn't be higher.
Advertisement
The MHRA's National Commission on AI in Healthcare is overdue its summer recommendations, just as NHS England accelerates a £10bn technology overhaul anchored by ambient voice tools whose regulatory footing remains, for now, provisional.
Fifteen NHS trusts have jointly procured an AI voice-transcription tool that saves six minutes a consultation and collapsed a six-month letter backlog to 14 days. But polling shows 81% of the public want explicit consent first - and regulators may be about to make that a legal requirement.
Yvette Cooper took charge of the DHSC just seven days ago. She has inherited the most ambitious AI deployment in NHS history - and a regulatory apparatus still racing to catch up.
NHS England is accelerating its biggest-ever AI deployment at the same moment the MHRA is rewriting the rulebook for every device behind it. The commercial sector's response, so far, is muted.
As NHS England accelerates a £10bn AI push backed by real pilot data, new research reveals the care sector is deploying AI at a pace its own governance frameworks cannot match - raising questions regulators have yet to answer.
The MHRA's 2025-26 Annual Report, laid before Parliament last week, declares a landmark year for AI regulation - but fresh market data and a blunt homecare survey reveal that most clinical AI operators still lack the brand protection and governance frameworks that regulators are increasingly expecting.
A West Midlands framework deal covering 70,000 clinicians and 1,239 GP practices marks a decisive shift from pilot to platform for AI clinical documentation - and tests whether ambient voice technology can hold up at NHS scale.
Fresh YouGov polling commissioned by Healthwatch England finds the public almost evenly split on AI scribes in NHS appointments, yet nearly 90% of recent patients had no idea whether one was used on them. The data lands directly in the inbox of regulators who must decide this summer how to govern a technology already spreading at pace.
The MHRA's 2025–26 Annual Report, laid before Parliament last week, confirms a year in which the regulator moved from studying AI to actively shaping its deployment - just as the National Commission's long-awaited recommendations are due this summer.
The MHRA has launched a live clinical AI sandbox in London NHS settings, just as fresh data shows a dramatic slowdown in new hospital activity companies and a widening split between care home tech enthusiasm and public trust.
One scan tells you if your brand is at risk in the UK, EU, US, JP and AU — plus the domains, socials and Companies House records you should be locking down at the same time.
5 jurisdictions · 2.8M UK marks indexed · Report in ~6 minutes
Configure your feed to get tailored updates on how AI is impacting your industry.